India's pharma takes 'wait-and-watch' approach to tackle Trump's 200% tariff plan | What next?
Donald Trump announced a plan to bring drug manufacturing back to the U.S., imposing zero tariffs on imported generics for two years, then increasing to 100% and 200%.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
